Balloon-Occluded Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single-Center US Preliminary Experience

• Published in: Journal of vascular and interventional radiology Vol. 30; no. 3; pp. 342 - 346
• Main Authors: Goldman, Daryl T., Singh, Manu, Patel, Rahul S., Nowakowski, F. Scott, Bishay, Vivian, Ranade, Mona, Lookstein, Robert A., Fischman, Aaron M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2019
• Subjects: DEE; HCC
• ISSN: 1051-0443; 1535-7732
• DOI: 10.1016/j.jvir.2018.11.026

This report describes a single-center experience with balloon-occluded transarterial chemoembolization for liver-directed therapy. A total of 26 patients (17 male, 9 female; mean age, 65 y ± 7) with 28 tumors (mean diameter, 2.7 cm; range, 1.1–5.9 cm) were treated. Technical success rate was 100% (28 of 28 cases), with 1 minor complication of left portal vein thrombosis and small liver infarct. Of the 15 tumors analyzed for response, 60% (9 of 15) exhibited complete response, 33.3% (5 of 15) exhibited partial response, and 6.6% (1 of 15) had stable disease on follow-up. Eight patients exhibited overall progression with a new hepatic lesion and a median time to progression of 7.9 months (range, 5–11 mo).